Consistent with constitutive IL-33 expression and release by dying cells, elevated IL-33 levels can be detected in a wide range of human diseases, including asthma, atopic dermatitis, ulcerative colitis, allergic rhinitis, and rheumatoid arthritis (31). This evidence concerns the gene IL33 and atopic eczema.